Monash Centre for Health Research and Implementation - MCHRI

Join our Consumer Advisory Panel!
If you are a women with type 2 diabetes, & have been pregnant or are considering pregnancy, we would love your help to shape our research. Find out more: https://bit.ly/4xIVcSP

Looking for a supportive space to ask questions, share experiences and connect with others on the PMOS journey? Join the AskPMOS Discussion Forum — a safe, moderated by Doctors, community where women, researchers and clinicians can come together to talk about the topics that matter most.

Whether you have a question, want to hear from others or simply feel less alone, the forum is here for you.

Join the conversation today: https://www.askpmos.org/discussion-forum/

Help us develop a tool for predicting early menopause.

All women aged 18-45 are invited to complete a short survey. Whether or not you have experienced early menopause, your voice matters.

Responses will help us create a tool that is relevant and useful for all women. Take the survey: https://bit.ly/4wToJsU

Thank you for your support!

Qualtrics Survey | Qualtrics Experience Management The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.

Hurry - only 2 days to go! Do you have PMOS or are you a health professional? Help us identify the most important questions in the next International Polyendocrine Metabolic Ovarian Syndrome (formerly PCOS) Guideline update.
Survey closes 6th August: bit.ly/4wUCffD

Professor Helena Teede and Associate Professor Aya Mousa have been awarded $3 million and $1.6 million NHMRC Investigator Grants respectively, for women's health and implementation research - Congratulations! 🎉

Director of MCHRI, Prof Teede was awarded another Level 3 Leadership Grant, which was scored as a Category 7, ranked in the top few nationally in the NHMRC Investigator Grants Leadership scheme. 👏

A/Prof Mousa, a mid-career researcher, has been awarded an Emerging Leadership 2 Grant, the second most competitive category in this year's scheme with a national funded rate of just 11.0%, marking her second consecutive NHMRC fellowship. 👏

About the research -

✅ Prof Teede’s Grant - Implementation research and impact: Optimising reproductive metabolic health including in high risk pregnancies - With rising obesity, we face a global epidemic of adverse reproductive metabolic health outcomes including polyendocrine metabolic ovarian syndrome (formerly PCOS), infertility and pregnancy complications, yet the interplay between metabolic and reproductive health is poorly appreciated. Here, new knowledge will define these impacts, identify those at greatest risk and uncover effective interventions that can be implemented to prevent and treat these conditions and to improve the health of women and children.

✅ A/Prof Mousa’s Grant - Precision Medicine in Gestational Diabetes: Exploring Insulin Physiology and Heterogeneity - will investigate metabolic pregnancy disorders such as gestational diabetes mellitus (GDM) which is driven by the body's inability to regulate insulin and affects 1 in 5 Australian pregnancies.

Despite affecting women differently, GDM is treated with a 'one-size-fits-all' approach. A/Prof Mousa’s globally recognised research program will clarify how insulin actions and related risks impact GDM and its complications, and will test a new precision approach to optimise treatment, reduce unnecessary insulin use and costs, and improve outcomes for women and their babies.

Read more: https://bit.ly/4hEyIxB

Congratulations to Professor Kirsten Palmer for being awarded $500,000 from health fund, HCF Australia, to develop a digital postpartum care pathway that helps new mums who have had high blood pressure during pregnancy, monitor blood pressure and receive personalised treatment adjustments from home.

By focusing on this important time after pregnancy, the project aims not only to improve blood pressure control at 12 months, but to shift care from reactive treatment to proactive prevention.

Thank you to HCF for funding this important Monash University PIVOT-HDP Project, which will empower women with the knowledge, tools, and ongoing support to improve cardiovascular outcomes for Australian women and their families.

❌ MYTH: PMOS is just reproductive condition.
✅ FACT: PMOS affects your whole body — including your heart ❤️

A new US study shows that women with PMOS (formerly PCOS) have a higher risk of cardiovascular disease than those without the condition 🔗 https://bit.ly/4gSW0j6. The study was led by AE-PMOS Society Executive, Prof Anuja Dokras, also a co-lead on the PMOS name change initiative.

In this ABC article ⬇️, Prof Helena Teede calls for better education and heart health checks for women with PMOS

For too long, PMOS has been misunderstood to be just a reproductive condition, but PMOS is a whole-body condition, with metabolic effects that are linked to cardiovascular health ❤️.

The Ask PMOS App is free and evidence-based, with resources and lifestyle information to help understand PMOS and heart health. Download it in the app store or at www.askpmos.org

https://www.abc.net.au/news/health/2026-07-21/pmos-linked-to-four-fold-increased-risk-of-heart-disease/106926086

PMOS/PCOS linked to 'significantly higher' stroke, heart attack risk Women with polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS) have a "significantly higher" risk of cardiovascular disease than those without, a new study suggests.

The International Polyendocrine Metabolic Ovarian Syndrome (formerly PCOS) Guideline is entering its next update and is seeking input from those with PMOS and health professionals. Help identify the most important questions to ask.
Take the survey: bit.ly/4wUCffD

🎉 We are thrilled to announce that MCHRI has been awarded $5M from the MRFF to transform pregnancy care for women with PMOS, who are currently missing out on care they need.

🤰 The Holistic Antenatal Pathways and Empowerment (HOPE)-PMOS Pregnancy Program will help ensure that the 13% of reproductive-aged Australian women with polyendocrine metabolic ovarian syndrome (PMOS) no longer fall through antenatal care gaps, with the condition currently recognised in only 2% to 4% of pregnancies or in one in five who have PMOS.

✅ Women with PMOS are at a significantly higher risk of pregnancy complications, including gestational diabetes, pre-eclampsia, and preterm birth. Preventive interventions for high risk pregnancies are applied effectively in the general population, but current antenatal care fails to identify women with PMOS, putting mothers with PMOS at even higher risk.

Chief Investigators and Co-Leads of the Program are Prof Helena Teede and Dr Jillian Tay. They will be working with MCHRI’s HOPE-PMOS research team, Dr Mahnaz Bahri Khomami, A/Prof Anju Joham, Prof Lisa Moran, A/Prof. Aya Mousa, PhD, A/Prof Cheryce Harrison, PhD, A/Prof Joanne Enticott, A/Prof Sandy Reeder, Prof Emily Callander, Lorna Berry and other CIs.

Read more about HOPE-PMOS : https://bit.ly/3R9vSpG